scPharmaceuticals. has been granted a patent for a liquid formulation containing furosemide, benzyl alcohol, and a tromethamine buffer. This formulation is designed to treat conditions such as congestion, edema, fluid overload, or hypertension, with specific concentrations and pH levels outlined in the claim. GlobalData’s report on scPharmaceuticals gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on scPharmaceuticals, Nanoparticle drug conjugates was a key innovation area identified from patents. scPharmaceuticals's grant share as of June 2024 was 25%. Grant share is based on the ratio of number of grants to total number of patents.
The granted patent US11998555B2 outlines a liquid pharmaceutical formulation primarily containing furosemide, a diuretic, or its pharmaceutically acceptable salts. The formulation includes benzyl alcohol in concentrations ranging from 0.1% to 10% (w/w) and a buffer comprising tromethamine or its salts, with a concentration between 25 mM and 100 mM. The furosemide concentration is specified to be greater than 40 mg/mL, and the pH of the formulation is maintained between 6.5 and 8.5. Additional claims detail variations in the concentration of benzyl alcohol and furosemide, as well as specific pH ranges.
The patent also describes a method for treating conditions such as congestion, edema, fluid overload, or hypertension by administering the formulation, which can be delivered via subcutaneous injection or infusion. A kit containing the unit liquid pharmaceutical formulation is also included, which may consist of multiple units. Furthermore, the formulation may incorporate additional components such as water, pH adjusters, and osmolarity adjusters, with specific examples provided for each category. The claims emphasize the formulation's versatility and potential applications in therapeutic settings.
To know more about GlobalData’s detailed insights on scPharmaceuticals, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
